A Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Combination of Menopur and Bravelle With Menopur Alone in Subjects Undergoing Assisted Reproductive Technology (ART)

Trial Profile

A Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Combination of Menopur and Bravelle With Menopur Alone in Subjects Undergoing Assisted Reproductive Technology (ART)

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2014

At a glance

  • Drugs Urofollitropin (Primary) ; Menotropin
  • Indications Female infertility
  • Focus Therapeutic Use
  • Acronyms COMBINE
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 06 Feb 2012 Actual patient number is 122 according to ClinicalTrials.gov.
    • 06 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Feb 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top